輸入代號或公司名稱後按 Enter
4745

合富-KY

+0.05 (+0.43%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
11.7013成交張數本益比0.27股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20252,956年增 -29.5%
毛利率202513.3%最新一期
營業利益率2025-9.3%最新一期
每股盈餘2025-3.18年增 -31900.0%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計71.4%74.1%77.4%77.7%78.3%79.4%80.4%79.5%81.1%86.7%
營業毛利(毛損)28.6%25.9%22.6%22.3%21.7%20.6%19.6%20.5%18.9%13.3%
營業毛利(毛損)淨額28.6%25.9%22.6%22.3%21.7%20.6%19.6%20.5%18.9%13.3%
推銷費用8.4%8.3%5.9%5.4%5.8%5.5%6.6%7.9%8.3%9.1%
管理費用10.4%9.4%7.5%7.5%7.3%7.9%5.9%7.2%8.0%9.6%
研究發展費用0.2%0.3%0.4%0.6%
預期信用減損損失(利益)0.1%0.7%1.4%0.6%0.4%-0.4%-0.1%3.2%
營業費用合計18.8%17.7%13.5%13.5%14.5%13.9%13.1%15.0%16.6%22.6%
營業利益(損失)9.9%8.2%9.1%8.8%7.2%6.6%6.6%5.5%2.3%-9.3%
利息收入0.4%0.2%0.7%0.4%0.3%0.7%
其他收入0.7%0.6%5.4%0.7%0.2%0.2%0.1%0.0%0.1%0.0%
其他利益及損失淨額-0.8%-0.1%-0.6%-0.1%-0.3%-0.0%-0.0%0.1%0.1%-0.3%
財務成本淨額0.8%0.9%0.9%0.7%0.8%0.5%0.4%0.7%0.7%0.8%
採用權益法認列之關聯企業及合資損益之份額淨額-0.1%-0.0%-0.0%0.0%0.0%0.0%-0.0%
營業外收入及支出合計-1.0%-0.3%3.9%-0.3%-0.5%-0.1%0.3%-0.1%-0.2%-0.3%
稅前淨利(淨損)8.9%7.9%13.0%8.5%6.7%6.5%6.9%5.4%2.1%-9.7%
所得稅費用(利益)合計3.0%2.2%5.4%1.2%2.2%2.3%2.7%2.5%1.0%1.5%
繼續營業單位本期淨利(淨損)5.9%5.7%7.6%7.2%4.4%4.2%4.2%2.9%1.1%-11.2%
本期淨利(淨損)5.9%5.7%7.6%7.2%4.4%4.2%4.2%2.9%1.1%-11.2%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-2.0%
不重分類至損益之項目:0.2%0.0%-0.1%0.0%0.0%-2.0%
國外營運機構財務報表換算之兌換差額-5.1%-1.5%-0.6%-2.2%0.8%-0.4%1.8%-1.9%5.0%-1.2%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目0.0%-0.0%
與可能重分類之項目相關之所得稅-0.3%-0.1%-0.2%-0.0%0.0%-0.0%0.1%-0.0%0.1%-0.0%
後續可能重分類至損益之項目:-2.2%0.8%-0.4%1.7%-1.9%5.0%-1.2%
其他綜合損益(淨額)-7.0%0.7%-1.2%-1.9%0.9%-0.6%1.8%-1.9%5.0%-3.1%
本期綜合損益總額-1.1%6.4%6.4%5.3%5.3%3.6%5.9%1.0%6.1%-14.3%
母公司業主(淨利∕損)5.9%5.7%7.3%6.0%2.6%2.7%1.7%1.0%0.0%-8.3%
非控制權益(淨利∕損)0.2%1.2%1.8%1.5%2.5%1.9%1.1%-2.9%
母公司業主(綜合損益)-1.1%6.4%6.2%3.8%3.1%2.2%3.0%0.0%2.8%-10.7%
非控制權益(綜合損益)0.2%1.5%2.1%1.4%3.0%1.0%3.3%-3.7%
基本每股盈餘0.1%0.1%0.1%0.1%0.0%0.0%0.0%0.0%0.0%-0.1%
稀釋每股盈餘0.1%0.1%0.1%0.1%0.0%0.0%0.0%0.0%0.0%-0.1%
確定福利計畫之再衡量數0.1%-0.5%-0.8%0.2%0.0%-0.1%0.0%0.0%
備供出售金融資產未實現評價損益-2.2%2.5%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。